| Laura Badjalimbe, | |
|
10977 Granada Ln Ste 105, Leawood, KS 66211-1415 | |
| (816) 822-0050 | |
| (816) 447-3960 |
| Full Name | Laura Badjalimbe |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 10 Years |
| Location | 10977 Granada Ln Ste 105, Leawood, Kansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336527134 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0300X | Internal Medicine - Geriatric Medicine | 53-76705-062 (Kansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Adventhealth Ottawa | Ottawa, KS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Adventhealth Ransom Memorial Inc | 4486996907 | 28 |
News Archive
In a comparison of two blood-thinning medications, heparin was associated with significantly fewer major cardiovascular events at 28 days than bivalirudin in patients receiving primary percutaneous coronary intervention after a heart attack, according to research presented at the American College of Cardiology's 63rd Annual Scientific Session.
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today reported additional clinical results for its lead product candidate, the Sufentanil NanoTab PCA System for the treatment of moderate-to-severe acute pain in the hospital setting.
Today's health policy headlines focus on highlights of President Obama's fiscal 2011 budget request and how it treats health-related programs. Meanwhile, in the background, health reform chatter continues.
IntelliCell BioSciences, Inc. announced today that it has filed a patent application for a new mechanical method to separate stromal vascular fraction (SVF) from the blood vessels in adipose tissue (fat) to be used clinically in regenerative medicine.
› Verified 4 days ago
| Entity Name | Adventhealth Ransom Memorial Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407319957 PECOS PAC ID: 4486996907 Enrollment ID: O20190510001418 |
News Archive
In a comparison of two blood-thinning medications, heparin was associated with significantly fewer major cardiovascular events at 28 days than bivalirudin in patients receiving primary percutaneous coronary intervention after a heart attack, according to research presented at the American College of Cardiology's 63rd Annual Scientific Session.
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today reported additional clinical results for its lead product candidate, the Sufentanil NanoTab PCA System for the treatment of moderate-to-severe acute pain in the hospital setting.
Today's health policy headlines focus on highlights of President Obama's fiscal 2011 budget request and how it treats health-related programs. Meanwhile, in the background, health reform chatter continues.
IntelliCell BioSciences, Inc. announced today that it has filed a patent application for a new mechanical method to separate stromal vascular fraction (SVF) from the blood vessels in adipose tissue (fat) to be used clinically in regenerative medicine.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Laura Badjalimbe, 10977 Granada Ln Ste 105, Leawood, KS 66211-1415 Ph: (816) 822-0050 | Laura Badjalimbe, 10977 Granada Ln Ste 105, Leawood, KS 66211-1415 Ph: (816) 822-0050 |
News Archive
In a comparison of two blood-thinning medications, heparin was associated with significantly fewer major cardiovascular events at 28 days than bivalirudin in patients receiving primary percutaneous coronary intervention after a heart attack, according to research presented at the American College of Cardiology's 63rd Annual Scientific Session.
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today reported additional clinical results for its lead product candidate, the Sufentanil NanoTab PCA System for the treatment of moderate-to-severe acute pain in the hospital setting.
Today's health policy headlines focus on highlights of President Obama's fiscal 2011 budget request and how it treats health-related programs. Meanwhile, in the background, health reform chatter continues.
IntelliCell BioSciences, Inc. announced today that it has filed a patent application for a new mechanical method to separate stromal vascular fraction (SVF) from the blood vessels in adipose tissue (fat) to be used clinically in regenerative medicine.
› Verified 4 days ago
Dr. Robert Mark Ross, MD Geriatric Medicine Medicare: Medicare Enrolled Practice Location: 12823 Sagamore Rd, Leawood, KS 66209 Phone: 913-449-1721 Fax: 913-498-2358 | |
Dr. Shelley Lynn Alexander, D.O. Geriatric Medicine Medicare: Not Enrolled in Medicare Practice Location: 10557 Mission Rd, Leawood, KS 66206 Phone: 913-213-6900 Fax: 913-213-6729 | |
Karl H Hanson Jr., M. D. Geriatric Medicine Medicare: Medicare Enrolled Practice Location: 9703 Overbrook Rd, Leawood, KS 66206 Phone: 913-381-0548 | |
Yelena Pinzur, D.O. Geriatric Medicine Medicare: Not Enrolled in Medicare Practice Location: 8800 State Line Rd, Leawood, KS 66206 Phone: 913-383-9099 Fax: 816-383-3103 | |
Stany A Dsilva, M.D. Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 8800 State Line Rd, Leawood, KS 66206 Phone: 913-383-9099 Fax: 913-383-3103 | |
Marcus A. Neubauer, M.D. Geriatric Medicine Medicare: Not Enrolled in Medicare Practice Location: 11805 Brookwood Ave, Leawood, KS 66211 Phone: 913-451-5620 |